Synthesis and Mutagenic Potency of Structural Isomers of 2-Amino-1-Methyl-6-Phenylimidazo[4,5-B]Pyridine

Citation

Chrisman, W., Tanga, M. J., & Knize, M. G. (2008). Synthesis and mutagenic potency of structural isomers of 2‐amino‐1‐methyl‐6‐phenylimidazo [4, 5‐b] pyridine. Journal of Heterocyclic Chemistry, 45(6), 1641-1649.

Abstract

Synthesis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), three structural isomers, and two desphenyl PhIP congeners has been carried out. Mutagenic potency was evaluated using S. typhimurium strain TA98 in the Ames test. Mutagenic potency increased in relation to structural features in these heterocyclic amines that allow extended resonance between the phenyl and imidazo[4,5-b]pyridine N2-amino substituents. By contrast, PhIP isomers, whose substitution disallows involvement of the phenyl group in their aminoimidazo resonance hybrids, and desphenyl congeners were from 86- to 234-fold less mutagenic than PhIP.

Synthesis-and-mutagenic-potency-of-structural-isomers-of-2-amino-1-methyl-6-phenylimidazo45-bpyridine diagram

Read more from SRI

  • A photo of Mary Wagner

    Recognizing the life and work of Mary Wagner 

    A cherished SRI colleague and globally respected leader in education research, Mary Wagner leaves behind an extraordinary legacy of groundbreaking work supporting children and youth with disabilities and their families.

  • Testing XRGo in a robotics laboratory

    Robots in the cleanroom

    A global health leader is exploring how SRI’s robotic telemanipulation technology can enhance pharmaceutical manufacturing.

  • SRI research aims to make generative AI more trustworthy

    Researchers have developed a new framework that reduces generative AI hallucinations by up to 32%.